▶ 調査レポート

世界の経粘膜ドラッグデリバリーデバイス市場 2021:企業別、地域別、種類・用途別

• 英文タイトル:Global Transmucosal Drug Delivery Devices Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

が調査・発行した産業分析レポートです。世界の経粘膜ドラッグデリバリーデバイス市場 2021:企業別、地域別、種類・用途別 / Global Transmucosal Drug Delivery Devices Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026 / GIR-105X17836資料のイメージです。• レポートコード:GIR-105X17836
• 出版社/出版日: / 2021年5月
• レポート形態:英文、PDF、107ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:Medical Devices & Consumables
• 販売価格(消費税別)
  Single User¥522,000 (USD3,480)▷ お問い合わせ
  Multi User¥783,000 (USD5,220)▷ お問い合わせ
  Corporate User¥1,044,000 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料では、経粘膜ドラッグデリバリーデバイスのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。経粘膜ドラッグデリバリーデバイスの種類別市場規模(頬側ルート、直腸ルート、鼻ルート)、用途別市場規模(病院、住宅)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・経粘膜ドラッグデリバリーデバイスの市場概要
・企業情報(企業概要、製品概要、販売量、価格、売上):Allergan、Amphastar Pharmaceuticals Inc、Aquestive Therapeutics Inc、ARS Pharmaceuticals、Combinent BioMedical Systems Inc、Aegis Therapeutics LLC、Bespak Europe Ltd、Callitas Therapeutics Inc
・企業別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年:頬側ルート、直腸ルート、鼻ルート
・用途別分析2016年-2026年:病院、住宅
・経粘膜ドラッグデリバリーデバイスの北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ
・経粘膜ドラッグデリバリーデバイスのヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア
・経粘膜ドラッグデリバリーデバイスのアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア
・経粘膜ドラッグデリバリーデバイスの南米市場規模2016年-2026年:ブラジル、アルゼンチン
・経粘膜ドラッグデリバリーデバイスの中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Transmucosal Drug Delivery Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Transmucosal Drug Delivery Devices size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Transmucosal Drug Delivery Devices market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Transmucosal Drug Delivery Devices market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Buccal Route
Rectal Route
Nasal Route

Market segment by Application can be divided into
Hospital
Residential

The key market players for global Transmucosal Drug Delivery Devices market are listed below:
Allergan
Amphastar Pharmaceuticals Inc
Aquestive Therapeutics Inc
ARS Pharmaceuticals
Combinent BioMedical Systems Inc
Aegis Therapeutics LLC
Bespak Europe Ltd
Callitas Therapeutics Inc

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

レポート目次

1 Market Overview
1.1 Transmucosal Drug Delivery Devices Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Transmucosal Drug Delivery Devices Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Buccal Route
1.2.3 Rectal Route
1.2.4 Nasal Route
1.3 Market Analysis by Application
1.3.1 Overview: Global Transmucosal Drug Delivery Devices Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Residential
1.4 Global Transmucosal Drug Delivery Devices Market Size & Forecast
1.4.1 Global Transmucosal Drug Delivery Devices Sales in Value (2016-2026))
1.4.2 Global Transmucosal Drug Delivery Devices Sales in Volume (2016-2026)
1.4.3 Global Transmucosal Drug Delivery Devices Price by Type (2016-2026) & (USD/Unit)
1.5 Global Transmucosal Drug Delivery Devices Production Capacity Analysis
1.5.1 Global Transmucosal Drug Delivery Devices Total Production Capacity (2016-2026)
1.5.2 Global Transmucosal Drug Delivery Devices Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Transmucosal Drug Delivery Devices Market Drivers
1.6.2 Transmucosal Drug Delivery Devices Market Restraints
1.6.3 Transmucosal Drug Delivery Devices Trends Analysis
2 Manufacturers Profiles
2.1 Allergan
2.1.1 Allergan Details
2.1.2 Allergan Major Business
2.1.3 Allergan Transmucosal Drug Delivery Devices Product and Services
2.1.4 Allergan Transmucosal Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Amphastar Pharmaceuticals Inc
2.2.1 Amphastar Pharmaceuticals Inc Details
2.2.2 Amphastar Pharmaceuticals Inc Major Business
2.2.3 Amphastar Pharmaceuticals Inc Transmucosal Drug Delivery Devices Product and Services
2.2.4 Amphastar Pharmaceuticals Inc Transmucosal Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Aquestive Therapeutics Inc
2.3.1 Aquestive Therapeutics Inc Details
2.3.2 Aquestive Therapeutics Inc Major Business
2.3.3 Aquestive Therapeutics Inc Transmucosal Drug Delivery Devices Product and Services
2.3.4 Aquestive Therapeutics Inc Transmucosal Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 ARS Pharmaceuticals
2.4.1 ARS Pharmaceuticals Details
2.4.2 ARS Pharmaceuticals Major Business
2.4.3 ARS Pharmaceuticals Transmucosal Drug Delivery Devices Product and Services
2.4.4 ARS Pharmaceuticals Transmucosal Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Combinent BioMedical Systems Inc
2.5.1 Combinent BioMedical Systems Inc Details
2.5.2 Combinent BioMedical Systems Inc Major Business
2.5.3 Combinent BioMedical Systems Inc Transmucosal Drug Delivery Devices Product and Services
2.5.4 Combinent BioMedical Systems Inc Transmucosal Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Aegis Therapeutics LLC
2.6.1 Aegis Therapeutics LLC Details
2.6.2 Aegis Therapeutics LLC Major Business
2.6.3 Aegis Therapeutics LLC Transmucosal Drug Delivery Devices Product and Services
2.6.4 Aegis Therapeutics LLC Transmucosal Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Bespak Europe Ltd
2.7.1 Bespak Europe Ltd Details
2.7.2 Bespak Europe Ltd Major Business
2.7.3 Bespak Europe Ltd Transmucosal Drug Delivery Devices Product and Services
2.7.4 Bespak Europe Ltd Transmucosal Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Callitas Therapeutics Inc
2.8.1 Callitas Therapeutics Inc Details
2.8.2 Callitas Therapeutics Inc Major Business
2.8.3 Callitas Therapeutics Inc Transmucosal Drug Delivery Devices Product and Services
2.8.4 Callitas Therapeutics Inc Transmucosal Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Transmucosal Drug Delivery Devices Sales by Manufacturer
3.1 Global Transmucosal Drug Delivery Devices Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Transmucosal Drug Delivery Devices Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Transmucosal Drug Delivery Devices
3.4 Market Concentration Rate
3.4.1 Top 3 Transmucosal Drug Delivery Devices Manufacturer Market Share
3.4.2 Top 6 Transmucosal Drug Delivery Devices Manufacturer Market Share
3.5 Global Transmucosal Drug Delivery Devices Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Transmucosal Drug Delivery Devices Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Transmucosal Drug Delivery Devices Market Size by Region
4.1.1 Global Transmucosal Drug Delivery Devices Sales in Volume by Region (2016-2026)
4.1.2 Global Transmucosal Drug Delivery Devices Revenue by Region (2016-2026)
4.2 North America Transmucosal Drug Delivery Devices Revenue (2016-2026)
4.3 Europe Transmucosal Drug Delivery Devices Revenue (2016-2026)
4.4 Asia-Pacific Transmucosal Drug Delivery Devices Revenue (2016-2026)
4.5 South America Transmucosal Drug Delivery Devices Revenue (2016-2026)
4.6 Middle East and Africa Transmucosal Drug Delivery Devices Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Transmucosal Drug Delivery Devices Sales in Volume by Type (2016-2026)
5.2 Global Transmucosal Drug Delivery Devices Revenue by Type (2016-2026)
5.3 Global Transmucosal Drug Delivery Devices Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Transmucosal Drug Delivery Devices Sales in Volume by Application (2016-2026)
6.2 Global Transmucosal Drug Delivery Devices Revenue by Application (2016-2026)
6.3 Global Transmucosal Drug Delivery Devices Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Transmucosal Drug Delivery Devices Sales by Type (2016-2026)
7.2 North America Transmucosal Drug Delivery Devices Sales by Application (2016-2026)
7.3 North America Transmucosal Drug Delivery Devices Market Size by Country
7.3.1 North America Transmucosal Drug Delivery Devices Sales in Volume by Country (2016-2026)
7.3.2 North America Transmucosal Drug Delivery Devices Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Transmucosal Drug Delivery Devices Sales by Type (2016-2026)
8.2 Europe Transmucosal Drug Delivery Devices Sales by Application (2016-2026)
8.3 Europe Transmucosal Drug Delivery Devices Market Size by Country
8.3.1 Europe Transmucosal Drug Delivery Devices Sales in Volume by Country (2016-2026)
8.3.2 Europe Transmucosal Drug Delivery Devices Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Transmucosal Drug Delivery Devices Sales by Type (2016-2026)
9.2 Asia-Pacific Transmucosal Drug Delivery Devices Sales by Application (2016-2026)
9.3 Asia-Pacific Transmucosal Drug Delivery Devices Market Size by Region
9.3.1 Asia-Pacific Transmucosal Drug Delivery Devices Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Transmucosal Drug Delivery Devices Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Transmucosal Drug Delivery Devices Sales by Type (2016-2026)
10.2 South America Transmucosal Drug Delivery Devices Sales by Application (2016-2026)
10.3 South America Transmucosal Drug Delivery Devices Market Size by Country
10.3.1 South America Transmucosal Drug Delivery Devices Sales in Volume by Country (2016-2026)
10.3.2 South America Transmucosal Drug Delivery Devices Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Transmucosal Drug Delivery Devices Sales by Type (2016-2026)
11.2 Middle East & Africa Transmucosal Drug Delivery Devices Sales by Application (2016-2026)
11.3 Middle East & Africa Transmucosal Drug Delivery Devices Market Size by Country
11.3.1 Middle East & Africa Transmucosal Drug Delivery Devices Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Transmucosal Drug Delivery Devices Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Transmucosal Drug Delivery Devices Typical Distributors
12.3 Transmucosal Drug Delivery Devices Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Transmucosal Drug Delivery Devices Revenue by Type, (USD Million), 2021-2026
Table 2. Global Transmucosal Drug Delivery Devices Revenue by Application, (USD Million), 2021-2026
Table 3. Allergan Basic Information, Manufacturing Base and Competitors
Table 4. Allergan Major Business
Table 5. Allergan Transmucosal Drug Delivery Devices Product and Services
Table 6. Allergan Transmucosal Drug Delivery Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Amphastar Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 8. Amphastar Pharmaceuticals Inc Major Business
Table 9. Amphastar Pharmaceuticals Inc Transmucosal Drug Delivery Devices Product and Services
Table 10. Amphastar Pharmaceuticals Inc Transmucosal Drug Delivery Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Aquestive Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table 12. Aquestive Therapeutics Inc Major Business
Table 13. Aquestive Therapeutics Inc Transmucosal Drug Delivery Devices Product and Services
Table 14. Aquestive Therapeutics Inc Transmucosal Drug Delivery Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. ARS Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 16. ARS Pharmaceuticals Major Business
Table 17. ARS Pharmaceuticals Transmucosal Drug Delivery Devices Product and Services
Table 18. ARS Pharmaceuticals Transmucosal Drug Delivery Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Combinent BioMedical Systems Inc Basic Information, Manufacturing Base and Competitors
Table 20. Combinent BioMedical Systems Inc Major Business
Table 21. Combinent BioMedical Systems Inc Transmucosal Drug Delivery Devices Product and Services
Table 22. Combinent BioMedical Systems Inc Transmucosal Drug Delivery Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Aegis Therapeutics LLC Basic Information, Manufacturing Base and Competitors
Table 24. Aegis Therapeutics LLC Major Business
Table 25. Aegis Therapeutics LLC Transmucosal Drug Delivery Devices Product and Services
Table 26. Aegis Therapeutics LLC Transmucosal Drug Delivery Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Bespak Europe Ltd Basic Information, Manufacturing Base and Competitors
Table 28. Bespak Europe Ltd Major Business
Table 29. Bespak Europe Ltd Transmucosal Drug Delivery Devices Product and Services
Table 30. Bespak Europe Ltd Transmucosal Drug Delivery Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Callitas Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table 32. Callitas Therapeutics Inc Major Business
Table 33. Callitas Therapeutics Inc Transmucosal Drug Delivery Devices Product and Services
Table 34. Callitas Therapeutics Inc Transmucosal Drug Delivery Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Global Transmucosal Drug Delivery Devices Sales by Manufacturer (2019-2021e) & (K Units)
Table 36. Global Transmucosal Drug Delivery Devices Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 37. Market Position of Manufacturers in Transmucosal Drug Delivery Devices, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 38. Global Transmucosal Drug Delivery Devices Production Capacity by Company, (K Units): 2020 VS 2021
Table 39. Head Office and Transmucosal Drug Delivery Devices Production Site of Key Manufacturer
Table 40. Global Transmucosal Drug Delivery Devices Sales by Region (2016-2021e) & (K Units)
Table 41. Global Transmucosal Drug Delivery Devices Sales by Region (2021-2026) & (K Units)
Table 42. Global Transmucosal Drug Delivery Devices Revenue by Region (2016-2021e) & (USD Million)
Table 43. Global Transmucosal Drug Delivery Devices Revenue by Region (2021-2026) & (USD Million)
Table 44. Global Transmucosal Drug Delivery Devices Sales by Type (2016-2021e) & (K Units)
Table 45. Global Transmucosal Drug Delivery Devices Sales by Type (2021-2026) & (K Units)
Table 46. Global Transmucosal Drug Delivery Devices Revenue by Type (2016-2021e) & (USD Million)
Table 47. Global Transmucosal Drug Delivery Devices Revenue by Type (2021-2026) & (USD Million)
Table 48. Global Transmucosal Drug Delivery Devices Price by Type (2016-2021e) & (USD/Unit)
Table 49. Global Transmucosal Drug Delivery Devices Price by Type (2021-2026) & (USD/Unit)
Table 50. Global Transmucosal Drug Delivery Devices Sales by Application (2016-2021e) & (K Units)
Table 51. Global Transmucosal Drug Delivery Devices Sales by Application (2021-2026) & (K Units)
Table 52. Global Transmucosal Drug Delivery Devices Revenue by Application (2016-2021e) & (USD Million)
Table 53. Global Transmucosal Drug Delivery Devices Revenue by Application (2021-2026) & (USD Million)
Table 54. Global Transmucosal Drug Delivery Devices Price by Application (2016-2021e) & (USD/Unit)
Table 55. Global Transmucosal Drug Delivery Devices Price by Application (2021-2026) & (USD/Unit)
Table 56. North America Transmucosal Drug Delivery Devices Sales by Country (2016-2021e) & (K Units)
Table 57. North America Transmucosal Drug Delivery Devices Sales by Country (2021-2026) & (K Units)
Table 58. North America Transmucosal Drug Delivery Devices Revenue by Country (2016-2021e) & (USD Million)
Table 59. North America Transmucosal Drug Delivery Devices Revenue by Country (2021-2026) & (USD Million)
Table 60. North America Transmucosal Drug Delivery Devices Sales by Type (2016-2021e) & (K Units)
Table 61. North America Transmucosal Drug Delivery Devices Sales by Type (2021-2026) & (K Units)
Table 62. North America Transmucosal Drug Delivery Devices Sales by Application (2016-2021e) & (K Units)
Table 63. North America Transmucosal Drug Delivery Devices Sales by Application (2021-2026) & (K Units)
Table 64. Europe Transmucosal Drug Delivery Devices Sales by Country (2016-2021e) & (K Units)
Table 65. Europe Transmucosal Drug Delivery Devices Sales by Country (2021-2026) & (K Units)
Table 66. Europe Transmucosal Drug Delivery Devices Revenue by Country (2016-2021e) & (USD Million)
Table 67. Europe Transmucosal Drug Delivery Devices Revenue by Country (2021-2026) & (USD Million)
Table 68. Europe Transmucosal Drug Delivery Devices Sales by Type (2016-2021e) & (K Units)
Table 69. Europe Transmucosal Drug Delivery Devices Sales by Type (2021-2026) & (K Units)
Table 70. Europe Transmucosal Drug Delivery Devices Sales by Application (2016-2021e) & (K Units)
Table 71. Europe Transmucosal Drug Delivery Devices Sales by Application (2021-2026) & (K Units)
Table 72. Asia-Pacific Transmucosal Drug Delivery Devices Sales by Region (2016-2021e) & (K Units)
Table 73. Asia-Pacific Transmucosal Drug Delivery Devices Sales by Region (2021-2026) & (K Units)
Table 74. Asia-Pacific Transmucosal Drug Delivery Devices Revenue by Region (2016-2021e) & (USD Million)
Table 75. Asia-Pacific Transmucosal Drug Delivery Devices Revenue by Region (2021-2026) & (USD Million)
Table 76. Asia-Pacific Transmucosal Drug Delivery Devices Sales by Type (2016-2021e) & (K Units)
Table 77. Asia-Pacific Transmucosal Drug Delivery Devices Sales by Type (2021-2026) & (K Units)
Table 78. Asia-Pacific Transmucosal Drug Delivery Devices Sales by Application (2016-2021e) & (K Units)
Table 79. Asia-Pacific Transmucosal Drug Delivery Devices Sales by Application (2021-2026) & (K Units)
Table 80. South America Transmucosal Drug Delivery Devices Sales by Country (2016-2021e) & (K Units)
Table 81. South America Transmucosal Drug Delivery Devices Sales by Country (2021-2026) & (K Units)
Table 82. South America Transmucosal Drug Delivery Devices Revenue by Country (2016-2021e) & (USD Million)
Table 83. South America Transmucosal Drug Delivery Devices Revenue by Country (2021-2026) & (USD Million)
Table 84. South America Transmucosal Drug Delivery Devices Sales by Type (2016-2021e) & (K Units)
Table 85. South America Transmucosal Drug Delivery Devices Sales by Type (2021-2026) & (K Units)
Table 86. South America Transmucosal Drug Delivery Devices Sales by Application (2016-2021e) & (K Units)
Table 87. South America Transmucosal Drug Delivery Devices Sales by Application (2021-2026) & (K Units)
Table 88. Middle East & Africa Transmucosal Drug Delivery Devices Sales by Country (2016-2021e) & (K Units)
Table 89. Middle East & Africa Transmucosal Drug Delivery Devices Sales by Country (2021-2026) & (K Units)
Table 90. Middle East & Africa Transmucosal Drug Delivery Devices Revenue by Country (2016-2021e) & (USD Million)
Table 91. Middle East & Africa Transmucosal Drug Delivery Devices Revenue by Country (2021-2026) & (USD Million)
Table 92. Middle East & Africa Transmucosal Drug Delivery Devices Sales by Type (2016-2021e) & (K Units)
Table 93. Middle East & Africa Transmucosal Drug Delivery Devices Sales by Type (2021-2026) & (K Units)
Table 94. Middle East & Africa Transmucosal Drug Delivery Devices Sales by Application (2016-2021e) & (K Units)
Table 95. Middle East & Africa Transmucosal Drug Delivery Devices Sales by Application (2021-2026) & (K Units)
Table 96. Direct Channel Pros & Cons
Table 97. Indirect Channel Pros & Cons
Table 98. Transmucosal Drug Delivery Devices Typical Distributors
Table 99. Transmucosal Drug Delivery Devices Typical Customers
List of Figures
Figure 1. Transmucosal Drug Delivery Devices Picture
Figure 2. Global Transmucosal Drug Delivery Devices Sales Market Share by Type in 2020
Figure 3. Buccal Route
Figure 4. Rectal Route
Figure 5. Nasal Route
Figure 6. Global Transmucosal Drug Delivery Devices Sales Market Share by Application in 2020
Figure 7. Hospital
Figure 8. Residential
Figure 9. Global Transmucosal Drug Delivery Devices Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 10. Global Transmucosal Drug Delivery Devices Market Size and Forecast (2016-2026) & (USD Million)
Figure 11. United States Transmucosal Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 12. Canada Transmucosal Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Mexico Transmucosal Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Germany Transmucosal Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. France Transmucosal Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. United Kingdom Transmucosal Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Russia Transmucosal Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Italy Transmucosal Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. China Transmucosal Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Japan Transmucosal Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Korea Transmucosal Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. India Transmucosal Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Southeast Asia Transmucosal Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Australia Transmucosal Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Brazil Transmucosal Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Egypt Transmucosal Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Saudi Arabia Transmucosal Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. South Africa Transmucosal Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Turkey Transmucosal Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Global Transmucosal Drug Delivery Devices Sales (2016-2026) & (K Units)
Figure 31. Global Transmucosal Drug Delivery Devices Production Capacity (2016-2026) & (K Units)
Figure 32. Global Transmucosal Drug Delivery Devices Production Capacity by Geographic Region: 2020 VS 2021
Figure 33. Transmucosal Drug Delivery Devices Market Drivers
Figure 34. Transmucosal Drug Delivery Devices Market Restraints
Figure 35. Transmucosal Drug Delivery Devices Market Trends
Figure 36. Global Transmucosal Drug Delivery Devices Sales Market Share by Manufacturer in 2020
Figure 37. Global Transmucosal Drug Delivery Devices Revenue Market Share by Manufacturer in 2020
Figure 38. Transmucosal Drug Delivery Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 39. Top 3 Transmucosal Drug Delivery Devices Manufacturer (Revenue) Market Share in 2020
Figure 40. Top 6 Transmucosal Drug Delivery Devices Manufacturer (Revenue) Market Share in 2020
Figure 41. Global Transmucosal Drug Delivery Devices Sales Market Share by Region (2016-2026)
Figure 42. Global Transmucosal Drug Delivery Devices Revenue Market Share by Region (2016-2026)
Figure 43. North America Transmucosal Drug Delivery Devices Revenue (2016-2026) & (USD Million)
Figure 44. Europe Transmucosal Drug Delivery Devices Revenue (2016-2026) & (USD Million)
Figure 45. Asia-Pacific Transmucosal Drug Delivery Devices Revenue (2016-2026) & (USD Million)
Figure 46. South America Transmucosal Drug Delivery Devices Revenue (2016-2026) & (USD Million)
Figure 47. Middle East & Africa Transmucosal Drug Delivery Devices Revenue (2016-2026) & (USD Million)
Figure 48. Global Transmucosal Drug Delivery Devices Sales Market Share by Type (2016-2026)
Figure 49. Global Transmucosal Drug Delivery Devices Revenue Market Share by Type (2016-2026)
Figure 50. Global Transmucosal Drug Delivery Devices Price by Type (2016-2026) & (USD/Unit)
Figure 51. Global Transmucosal Drug Delivery Devices Sales Market Share by Application (2016-2026)
Figure 52. Global Transmucosal Drug Delivery Devices Revenue Market Share by Application (2016-2026)
Figure 53. Global Transmucosal Drug Delivery Devices Price by Application (2016-2026) & (USD/Unit)
Figure 54. North America Transmucosal Drug Delivery Devices Sales Market Share by Country (2016-2026)
Figure 55. North America Transmucosal Drug Delivery Devices Revenue Market Share by Country (2016-2026)
Figure 56. North America Transmucosal Drug Delivery Devices Sales Market Share by Type (2016-2026)
Figure 57. North America Transmucosal Drug Delivery Devices Sales Market Share by Application (2016-2026)
Figure 58. Europe Transmucosal Drug Delivery Devices Sales Market Share by Country (2016-2026)
Figure 59. Europe Transmucosal Drug Delivery Devices Revenue Market Share by Country (2016-2026)
Figure 60. Europe Transmucosal Drug Delivery Devices Sales Market Share by Type (2016-2026)
Figure 61. Europe Transmucosal Drug Delivery Devices Sales Market Share by Application (2016-2026)
Figure 62. Asia-Pacific Transmucosal Drug Delivery Devices Sales Market Share by Region (2016-2026)
Figure 63. Asia-Pacific Transmucosal Drug Delivery Devices Revenue Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Transmucosal Drug Delivery Devices Sales Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Transmucosal Drug Delivery Devices Sales Market Share by Application (2016-2026)
Figure 66. South America Transmucosal Drug Delivery Devices Sales Market Share by Country (2016-2026)
Figure 67. South America Transmucosal Drug Delivery Devices Revenue Market Share by Country (2016-2026)
Figure 68. South America Transmucosal Drug Delivery Devices Sales Market Share by Type (2016-2026)
Figure 69. South America Transmucosal Drug Delivery Devices Sales Market Share by Application (2016-2026)
Figure 70. Middle East & Africa Transmucosal Drug Delivery Devices Sales Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Transmucosal Drug Delivery Devices Revenue Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Transmucosal Drug Delivery Devices Sales Market Share by Type (2016-2026)
Figure 73. Middle East & Africa Transmucosal Drug Delivery Devices Sales Market Share by Application (2016-2026)
Figure 74. Sales Channel: Direct Channel vs Indirect Channel
Figure 75. Methodology
Figure 76. Research Process and Data Source